2019
DOI: 10.21203/rs.2.17162/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Neuropathological changes in dorsal root ganglia induced by pyridoxine in dogs

Abstract: Background: Pyridoxine (PDX), vitamin B 6 , is an essential vitamin. PDX deficiency induces various symptoms and abuse of PDX supplement also acts as a neurotoxicant that induces severe sensory neuropathy. Results: To construct a sensory neuropathy model in dogs, excess pyridoxine (PDX) was injected subcutaneously into dogs for seven days and dorsal root ganglia (DRG) were observed at 0, 1 and 4 weeks after the last PDX treatment. During the administration period, body weight loss and proprioceptive loss occur… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…Proteins commonly used to evaluate cell-and structure-specific neurotoxicity via immunohistochemistry were identified as candidate biomarkers for DRG toxicity. This included: i) UCH-L1 for neurons (Wilson et al, 1988), ii) Tau and NF-L for axons (Kanaan and Grabinski, 2021;Mages et al, 2018), iii) microtubule-associated protein 2 (MAP2) for neuron dendrites (Gumy et al, 2017), iv) GFAP for astrocytes (Yun et al, 2020), v) 2',3'-cyclic-nucleotide 3'phosphodiesterase (CNPase) for oligodendrocytes (Toma et al, 2007), and vi) ionized calcium binding adaptor molecule 1 (IBA1) for microglia (CNS) and macrophages (PNS) (Yun et al, 2020).…”
Section: Identification Of Cell-specific Candidate Biomarkersmentioning
confidence: 99%
“…Proteins commonly used to evaluate cell-and structure-specific neurotoxicity via immunohistochemistry were identified as candidate biomarkers for DRG toxicity. This included: i) UCH-L1 for neurons (Wilson et al, 1988), ii) Tau and NF-L for axons (Kanaan and Grabinski, 2021;Mages et al, 2018), iii) microtubule-associated protein 2 (MAP2) for neuron dendrites (Gumy et al, 2017), iv) GFAP for astrocytes (Yun et al, 2020), v) 2',3'-cyclic-nucleotide 3'phosphodiesterase (CNPase) for oligodendrocytes (Toma et al, 2007), and vi) ionized calcium binding adaptor molecule 1 (IBA1) for microglia (CNS) and macrophages (PNS) (Yun et al, 2020).…”
Section: Identification Of Cell-specific Candidate Biomarkersmentioning
confidence: 99%
“…Overall, SGCs appear to be a plastic cell population with multiple functional roles. Although the interest in this cell population is growing, few studies have specifically dealt with canine SGCs (cSGCs), and current knowledge of cSGCs is scarce in comparison to murine (mSGCs) and rat SGCs 23‐25 . The dog is of particular interest as it represents a suitable translational large animal model for certain canine and human CNS diseases, including spinal cord injury.…”
Section: Introductionmentioning
confidence: 99%
“…Although the interest in this cell population is growing, few studies have specifically dealt with canine SGCs (cSGCs), and current knowledge of cSGCs is scarce in comparison to murine (mSGCs) and rat SGCs. [23][24][25] The dog is of particular interest as it represents a suitable translational large animal model for certain canine and human CNS diseases, including spinal cord injury. Dogs show comparable pathogenic mechanisms, lesion distribution and morphology as well as clinical manifestations.…”
mentioning
confidence: 99%